|
Friday 31st January 2003 |
Text too small? |
The result ended a two-year run of losses for the company, in which Eric Watson's Cullen Investments owns a controlling 53% stake.
Revenue rose 58% to $27.1 million, with growth coming mainly from the company's entry into diagnostics. The aged care and rehabilitation divisions also turned in improved performances.
Managing director Alan Clarke said the 28% annualised revenue growth rate achieved since the company began its repositioning in 2000 was expected to continue into the 2004 financial year and beyond.
Interests costs fell 20% as a result of refinancing and debt reduction.
No comments yet
CEN - Contact Chair to retire this year, new Chair appointed
May 1st Morning Report
GTK - Gentrack's Veovo Acquires Dubai Technology Partners
SML - Additional information following Bright Dairy announcement
April 30th Morning Report
Rua Bioscience Market Update
FSF - Fonterra announces interim leadership changes
April 29th Morning Report
NZK - Blue Endeavour Pilot Farm and Wellboat Update
TRU - FY 31 March 2026 Revenue and Results Guidance Achieved